NBIX: Neurocrine Biosciences Earnings per share for the last twelve months

Symbol and logo of brand Neurocrine Biosciences Inc (NBIX)

Neurocrine Biosciences (NBIX) is implementing ESG standards by optimizing laboratory energy consumption and bioethics. The current EPS TTM on the GURU.Markets daily chart shows that the indicator stands at 6.75. This reflects the efforts of strong management in bringing drugs to market, although the company continues to strive to overcome its dependence on a single core product through portfolio diversification.

NBIX (Neurocrine Biosciences) Net earnings per share for the last 12 months history from 07/04/2022 to 11/18/2026

Metric breakdowns and analytics for Neurocrine Corp (NBIX)

- current quotes and average value forecast:
Fundamental valuation:Neurocrine Corp (NBIX)
Manufactured products of Neurocrine Biosciences Inc

Earnings per share (EPS TTM) is calculated by dividing the total net income over the last four quarters by the total number of shares, allowing for an assessment of actual capital management efficiency. By analyzing the trailing twelve-month earnings per share, an investor can see how the scaling of sales at Neurocrine Biosciences (NBIX) overcomes the R&D cost threshold, transforming operating leverage into profit growth.

Main competitors

biogen.com - Net earnings per share (EPS TTM)|RGC (Regencell Bioscience Holdings Limited) - Earnings per share for the last 12 months|Axsome Corp (AXSM) - Earnings per share for the last twelve months|ACAD - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months XENE|VKTX - Net earnings per share for the trailing year|Net earnings per share for the last 12 months SUPN (supernus.com)|Net earnings per share for the last four quarters Catalyst Pharmaceuticals Inc|Denali Therapeutics Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year HRMY|BHVN: Net earnings per share for the last 12 months|Earnings per share for the trailing year AMLX (Amylyx Pharmaceuticals)|Trevi Therapeutics, Inc. (TRVI) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Praxis Precision Medicines, Inc. (PRAX)|AVXL (anavex.com) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CBLL (CeriBell Corp)|Earnings per share for the last twelve months Prothena Biosciences (PRTA)|Net earnings per share for the last four quarters Alector|Net earnings per share (EPS TTM) ANNX (annexonbio.com)|Earnings per share for the trailing year OMER|NGNE: Net earnings per share for the last 12 months|ACIU (AC Immune Corp) - Earnings per share for the last 12 months|VYGR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neumora Therapeutics, Inc. (NMRA)|SCLX (Scilex Holding) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months TVGN (Tevogen Bio)|Net earnings per share (EPS TTM) ACOG|CGTX - Net earnings per one share for the last twelve months|Inhibikase Pharma - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters cassavasciences.com (SAVA)|Assertio Holdings - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Coya Therapeutics COYA|VTGN: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months OVID|Earnings per share for the last twelve months Acumen Pharmaceuticals|CRVO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATHE|CLNN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months PepGen Inc PEPG|Net earnings per share for the last four quarters jupiterneurosciences.com (JUNS)|Relmada Therapeutics, Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ANVS (annovisbio.com)|Grace Tx (GRCE) - Earnings per share for the last twelve months|Firefly Neuroscience (AIFF) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Klotho Neurosciences Inc|neurosense-tx.com (NRSN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Net earnings per share (EPS TTM) MetaVia, Inc. (MTVA)|NeurAxis, Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Helius Medical HSDT|PASG - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Neuphoria Therapeutics, Inc.|Minerva Neurosciences Inc (NERV) - Earnings per share for the last twelve months|Athira Pharma, Inc. - Earnings per share for the trailing year|ADXN (Addex) - Net earnings per share (EPS TTM)|Alzamend Neuro, Inc. - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CYCN|PTIX - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months pasitheaclinics.com KTTA|Earnings per share for the trailing year CRGT|Avenue Therapeutics Inc - Net earnings per share (EPS TTM)|Brainstorm Cell Therapeutics, Inc. (BCLI) - Net earnings per share for the last 12 months|CARA: Net earnings per share (EPS TTM)|Chromocell - Earnings per share for the trailing year|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|ITCI (intracellulartherapies.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Longboard Pharma (LBPH)|Marinus - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGN (nkgenbiotech.com)|NeuroBo Pharma - Earnings per share for the last twelve months|Sage Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SNPX (Synaptogenix, Inc.)|TRVN (trevena.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Vigil Neuroscience Inc.|Earnings per share for the last twelve months Anew Medical|CERE: Earnings per share for the trailing year